Atlas Trials

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets

Clinical trial NCT04499443 · UNKNOWN

Trial details

NCT number
NCT04499443
Sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis B
Start date
2020-08-18
Primary completion
2021-03-31
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.